A new study from Columbia University and an international team of researchers identifies multiple ways to achieve the same health benefits from exercise — as long as the… read more.
Genentech, announced new 2-year data from Part 2 of FIREFISH, a Phase II/III global study evaluating Evrysdi (risdiplam) in infants aged 1-7 months at enrollment with symptomatic Type… read more.
Roche announced that the European Commission (EC) has approved Evrysdi (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients two months of age and older,… read more.
Interview and article by Christine Clark. Dr Megan Hanlon and Professor Ursula Fearon describe the implications of their research findings for future practice and research in rheumatoid arthritis…. read more.
Interview and article by Christine Clark. Recent research into the molecular basis for rheumatoid arthritis may be pointing the way to targeted therapy to prevent inflammation and joint… read more.
Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), adopted a positive opinion for the use of once-weekly… read more.
Article written by Bruce Sylvester Antidepressants do not appear to provide significant back or osteoarthritis pain relief, even though they are widely prescribed for such purposes, researchers reported… read more.
Interview and article by Christine Clark A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) used distance matrices to match RA cases… read more.
Interview and article by Chrstine Clark The findings of a recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) could have important implications… read more.
Interview and article by Christine Clark A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) produced a number of interesting findings, Dr… read more.
Interview and article by Christine Clark. Rheumatoid arthritis (RA) affects about one percent of the population in the UK and comorbidities are reported to be common. A recent… read more.
Article written by Bruce Sylvester Researchers report that methotrexate is an effective treatment for people with knee osteoarthritis (OA) who have pain and inflammation.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
